Carolyn in Deputy Head of Technology Transfer at Oxford University Innovation. Since joining Oxford University Innovation Carolyn has led or mentored the formation of 14 spin-out companies from Oxford University commercialising a diversity of innovative technologies addressing distinct challenges in healthcare. She sits on the board of 4 of these companies. Recent Oxford spin-outs include Vaccitech, Evox and Oxstem collectively raising £36.9M in seed financing. Prior to Oxford University Innovation, Carolyn worked in senior Business Development roles in Novartis and Chiron and in the Mergers and Acquisitions team at Ernst & Young. Previously Carolyn held post doc positions at Oxford University in the fields of cell signalling and immunology. She has a first class honours degree in Pharmacology from University College Dublin, a PhD in Immunology from Trinity College Dublin and an MBA from Warwick University.